Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × Diffusion Magnetic Resonance Imaging × Clear all

Status

Unknown 3 Completed 3 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Observation 20 Blood Specimen Collection 18 Drug Therapy 14 Surveys and Questionnaires 12 Surgical Procedures, Operative 8 Immune Checkpoint Inhibitors 8 Immunotherapy 7 Watchful Waiting 5 Positron Emission Tomography Computed Tomography 5 Hematologic Tests 5 Bevacizumab 5 Neoadjuvant Therapy 4 Fluorodeoxyglucose F18 4 Docetaxel 4 tislelizumab 3 envafolimab 3 darolutamide 3 Tyrosine Kinase Inhibitors 3 Radiotherapy 3 Radiofrequency Ablation 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Letrozole 3 Indocyanine Green 3 Imatinib Mesylate 3 Endosonography 3 Endoscopic Mucosal Resection 3 Cyclophosphamide 3 Capecitabine 3 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡